Skip to main content
David Steinhaus, MD, Cardiology, Minneapolis, MN

DavidMichaelSteinhausMD

Cardiology • Minneapolis, MN

Adult Congenital Heart Disease, Cardiac Electrophysiology

Vice President Medtronic

Join to view full profile

Dr. Steinhaus is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Steinhaus' full profile

Already have an account?

  • Office

    200 Park Ave
    Minneapolis, MN 55415
    Phone+1 763-514-3577

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Clinical Cardiac Electrophysiology, 1983 - 1984
  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Cardiovascular Disease, 1980 - 1983
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1977 - 1980
  • Harvard Medical School
    Harvard Medical SchoolClass of 1977

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 1984 - 2026
  • KS State Medical License
    KS State Medical License 1996 - 2025
  • MN State Medical License
    MN State Medical License 2006 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Medtronic’s Implantable System for Remodulin to Treat Patients with Pulmonary Arterial Hypertension Gets FDA Approval
    Medtronic’s Implantable System for Remodulin to Treat Patients with Pulmonary Arterial Hypertension Gets FDA ApprovalAugust 9th, 2018
  • FDA Approves Medtronic’s Implantable System for Remodulin to Treat PAH
    FDA Approves Medtronic’s Implantable System for Remodulin to Treat PAHAugust 1st, 2018
  • Medtronic, United Receive Approval for Fully Implantable PAH Infusion Pump
    Medtronic, United Receive Approval for Fully Implantable PAH Infusion PumpAugust 1st, 2018
  • Join now to see all

Professional Memberships

Dr. David Steinhaus, Dr. David Steinhaus, MD, Dr. D Steinhaus, Dr. David Michael Steinhaus